Takeda R&D Chief Andy Plump to Retire in June After 12 Years
Macro·2 articles across 2 outlets
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Andy Plump, M.D., Ph.D., president of research and development at Takeda, is set to leave the company in June. Plump joined Takeda during a turbulent period, pushed the company to work more closely with young biotechs and will leave it with what CEO Julie Kim called a “lasting foundation.”
TakedaAndy Plump
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“<p>Plump joined Takeda during a turbulent period, pushed the company to work more closely with young biotechs and will leave it with what CEO Julie Kim called a “lasting foundation.”</p>”
biopharma dive — Andy Plump, architect of Takeda’s R&D overhaul, to retire next year“Takeda President of Research and Development Andy Plump, M.D., Ph.D., is leaving the company in June after twelve years in the position.”
fierce biotech — <a href="/biotech/chutes-ladders-longtime-takeda-rd-chief-depart-next-june" hreflang="en">Chutes & Ladders—Longtime Takeda R&D chief to depart next June</a>“Andy Plump, M.D., Ph.D., president of research and development at Takeda, is set to leave the company in June.”
fierce biotech — <a href="/biotech/takedas-long-serving-rd-chief-andy-plump-retire-wake-pipeline-successes" hreflang="en">Takeda’s long-serving R&D chief Andy Plump to retire in wake of pipeline successes</a>